Inhalable dry powders of a monoclonal antibody against SARS-CoV-2 virus made by thin-film freeze-drying.
Xu H, Sahakijpijarn S, Moon C, Emig CJ, Mena M, Henry SJ, Vitug A, Ventura CJ, Kuehl PJ, Revelli D, Owens DE 3rd, Christensen DJ, Williams RO 3rd, Cui Z.
Xu H, et al. Among authors: vitug a.
Int J Pharm. 2024 Sep 5;662:124511. doi: 10.1016/j.ijpharm.2024.124511. Epub 2024 Jul 25.
Int J Pharm. 2024.
PMID: 39067548